デフォルト表紙
市場調査レポート
商品コード
1333569

幹細胞アッセイの世界市場

Stem Cell Assays

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
幹細胞アッセイの世界市場
出版日: 2023年08月21日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

幹細胞アッセイの世界市場は2030年までに69億米ドルに達する

COVID-19後のビジネス環境が変化する中、2022年に19億米ドルと推定される幹細胞アッセイの世界市場は、2030年には69億米ドルに達すると予測され、2022年から2030年にかけてCAGR 17.8%で成長すると予測されます。本レポートで分析したセグメントの一つである機器は、CAGR18.3%を記録し、分析期間終了時には54億米ドルに達すると予測されています。現在進行中のパンデミック後の回復を考慮し、キット分野の成長は今後8年間のCAGRを17.6%に修正しました。

米国市場は推定5億5,080万米ドル、中国はCAGR16.5%で成長予測

米国の幹細胞アッセイ市場は、2022年には5億5,080万米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR16.5%で推移し、2030年には市場規模が11億米ドルに達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ16.2%と15.2%の成長が予測されています。欧州では、ドイツがCAGR約12.8%で成長すると予測されています。

調査対象企業の例

  • Antria, Inc.
  • Applied StemCell, Inc.
  • Beike Biotechnology Co., Ltd.
  • BioGenCell
  • BioRestorative Therapies
  • Bio-Techne Corporation
  • Celltex Therapeutics
  • Century Therapeutics
  • Cynata Therapeutics Ltd.
  • Forever Labs, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP15020

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Stem Cell Assays Market to Reach $6.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Stem Cell Assays estimated at US$1.9 Billion in the year 2022, is projected to reach a revised size of US$6.9 Billion by 2030, growing at aCAGR of 17.8% over the period 2022-2030. Instruments, one of the segments analyzed in the report, is projected to record 18.3% CAGR and reach US$5.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kits segment is readjusted to a revised 17.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $550.8 Million, While China is Forecast to Grow at 16.5% CAGR

The Stem Cell Assays market in the U.S. is estimated at US$550.8 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 16.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.2% and 15.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.

Select Competitors (Total 44 Featured) -

  • Antria, Inc.
  • Applied StemCell, Inc.
  • Beike Biotechnology Co., Ltd.
  • BioGenCell
  • BioRestorative Therapies
  • Bio-Techne Corporation
  • Celltex Therapeutics
  • Century Therapeutics
  • Cynata Therapeutics Ltd.
  • Forever Labs, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Stem Cell Assay - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cell Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Cell Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Differentiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Differentiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Isolation & Purification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Isolation & Purification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Proliferation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Proliferation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Apoptosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Apoptosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for hESCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for hESCs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 23: World Stem Cell Assays Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Stem Cell Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 25: World 8-Year Perspective for Stem Cell Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 27: World 8-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World 8-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 31: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Viability / Cytotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 33: World 8-Year Perspective for Viability / Cytotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: USA 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: USA 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: USA 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • CANADA
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Canada 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Canada 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Canada 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • JAPAN
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Japan 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Japan 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • CHINA
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 58: China Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: China 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: China 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: China 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • EUROPE
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Europe 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Europe 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 73: Europe 8-Year Perspective for Stem Cell Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • FRANCE
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 76: France Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: France 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: France 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: France 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • GERMANY
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Germany 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Germany 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Germany 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Italy 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Italy 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • UNITED KINGDOM
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 100: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 101: UK 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 103: UK 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 107: UK 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Rest of World 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 127: Rest of World 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of World 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 131: Rest of World 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030

IV. COMPETITION